Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

The ability to discriminate between Alzheimer’s disease (AD), subcortical vascular disease, and other cognitive disorders is crucial for diagnostic purposes and clinical trial outcomes. Patients with primarily subcortical vascular disease are unlikely to benefit from treatments targeting the AD path...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallin, Anders, Nordlund, Arto, Jonsson, Michael, Blennow, Kaj, Zetterberg, Henrik, Öhrfelt, Annika, Stålhammar, Jacob, Eckerström, Marie, Carlsson, Mårten, Olsson, Erik, Göthlin, Mattias, Svensson, Johan, Rolstad, Sindre, Eckerström, Carl, Bjerke, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702291/
https://www.ncbi.nlm.nih.gov/pubmed/26219595
http://dx.doi.org/10.1038/jcbfm.2015.148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702291/
https://www.ncbi.nlm.nih.gov/pubmed/26219595
http://dx.doi.org/10.1038/jcbfm.2015.148

Ejemplares similares